Erin Davis, Ph.D.

Erin joined X-Chem as their Chief Technology Officer in 2024 with a focus on advancing the company’s strategy of utilizing wet and in silico data generation systems to enhance its position as a drug discovery partner. She oversees the development of a comprehensive discovery platform that integrates DEL, medicinal and computational science, and machine learning, supporting all facets of the pre-clinical discovery process. Previously, Erin served as senior vice president of enterprise informatics at Schrödinger, at the helm of the business, science, and development aspects of its enterprise informatics and modeling platform, LiveDesign. She drove the platform’s explosive growth across the global pharmaceutical industry, supporting an evolution of integrative modeling-based drug discovery. She also founded the discovery informatics team, supporting technology development across Schrödinger’s internal drug discovery programs.

Prior to joining Schrödinger, Erin held several technology leadership positions supporting better drug discovery, including head of US consulting for Chemaxon and US scientific relations manager for the Cambridge Crystallographic Data Centre. Before moving to industry, Erin spent several years in academia at the medicinal and computational chemistry interface, wishing for better tools while researching neurochemical and antimicrobial drug design. She earned a Ph.D. from the University of Montana in 2006 with a focus on the computational design of CNS compounds.

Back to Team